Among the novel biological agents for lupus nephritis, renal response within a specific therapeutic time window improves with obinutuzumab, abatacept, and belimumab, investigators report.

Three different versions of Alexandria Wingate appear in a trio of purple paintings the Baltimorean started while a fine art ...

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

A U.S. judge ruled that Regeneron Pharmaceuticals cannot immediately block U.S. sales of a proposed copy of its blockbuster ...

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

Ilaris, which treats conditions including Still’s disease, can cause side effects such as unexpected weight gain. Learn about ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

A new study takes a look at a controversial medication recommended by some in the early days of the COVID-19 pandemic. KYW ...

Biogen and UCB said an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal ...

Objectives The lupus low disease activity state (LLDAS ... Comparison among the three subsets of LLDAS visits showed no ...